Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
为高危患者群体设计 SARS-CoV-2 T 细胞诱导疫苗
期刊:Vaccines
影响因子:
doi:10.3390/vaccines9050428
Hans-Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, Reinhild Klein, Beate Preuß, Juliane Sarah Walz, Annika Nelde, Sebastian P Haen, Michael Reth, Jianying Yang, Ghazaleh Tabatabai, Hans Bösmüller, Helen Hoffmann, Michael Schindler, Oliver Planz, Karl-Heinz Wiesmüller, Markus W Löffler6